» Articles » PMID: 29556920

The Effect of Temazepam on Assessment of Severity of Obstructive Sleep Apnea by Polysomnography

Overview
Journal Sleep Breath
Publisher Springer
Date 2018 Mar 21
PMID 29556920
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the effect of temazepam on assessment of the severity of obstructive sleep apnea (OSA) by polysomnography (PSG).

Methods: Analysis of diagnostic laboratory-PSG studies was performed in OSA patients who were administered temazepam (10 mg) to facilitate sleep ("temazepam group", n = 73) and in OSA patients (matched for age, gender, body mass index and study date) in whom temazepam was not administered ("control group", n = 73). Sleep- and respiratory-related variables were compared between the groups for the (i) first 3 h of study following temazepam in the temazepam group (when peak blood concentration is expected) or following lights out in the control group, and (ii) entire study duration.

Results: Within the first 3 h, no differences in sleep-related variables were observed between the groups. Over the entire study duration, the temazepam group had a reduced total sleep time compared to the control group, likely due to the overnight sleep difficulties that led to its use. Whether measured during the first 3 h of study or over the entire study duration, no significant differences were detected between the groups for any respiratory-related variable, including apnea hypopnea index, arousal index, oxygen desaturation, apnea index, hypopnea index, and event duration. When patients were considered in terms of OSA severity, decreased arousal index was noted in the temazepam group over the entire study duration, but only in those with severe OSA.

Conclusion: Oral administration of 10 mg of temazepam during the course of PSG does not systematically affect assessment of the severity of OSA by PSG.

Citing Articles

A Novel Approach for Sleep Arousal Disorder Detection Based on the Interaction of Physiological Signals and Metaheuristic Learning.

Badiei A, Meshgini S, Rezaee K Comput Intell Neurosci. 2023; 2023:9379618.

PMID: 36688224 PMC: 9859692. DOI: 10.1155/2023/9379618.


Response to a letter to the editor by Mohammad Rasoul Ghadami et al.: "Obstructive sleep apnea in veterans with post-traumatic stress disorder: looking beyond their complaint".

Rezaeitalab F, Mokhber N, Ravanshad Y, Saberi S, Rezaeetalab F Sleep Breath. 2018; 23(1):295-296.

PMID: 30105584 DOI: 10.1007/s11325-018-1707-6.

References
1.
Holbrook A, Crowther R, Lotter A, Cheng C, King D . Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000; 162(2):225-33. PMC: 1232276. View

2.
Mendelson W, Garnett D, Gillin J . Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis. 1981; 169(4):261-4. DOI: 10.1097/00005053-198104000-00012. View

3.
Hoijer U, Hedner J, Ejnell H, Grunstein R, Odelberg E, Elam M . Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J. 1994; 7(11):2011-5. View

4.
Berry R, McCasland C, Light R . The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis. 1992; 146(5 Pt 1):1256-60. DOI: 10.1164/ajrccm/146.5_Pt_1.1256. View

5.
Berry R, Kouchi K, Bower J, Prosise G, Light R . Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1995; 151(2 Pt 1):450-4. DOI: 10.1164/ajrccm.151.2.7842205. View